Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Chronic Kidney Disease Stage 3B

Tundra lists 4 Chronic Kidney Disease Stage 3B clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT06394544

Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment

The aim of this study is to evaluate the effects of Brazil nut supplementation on inflammation, oxidative stress and intestinal microbiota in patients with chronic kidney disease undergoing conservative treatment.

Gender: All

Ages: 20 Years - 59 Years

Updated: 2025-04-03

1 state

Chronic Kidney Diseases
Chronic Kidney Disease stage3
Chronic Kidney Disease Stage 3A
+6
RECRUITING

NCT05489120

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

The KDOQI 2020 - Clinical practice guideline for nutrition in chronic kidney disease (CKD) -recommends protein restriction to reduce the risk of end-stage renal disease/death and improve quality of life, a low protein diet providing 0.55-0.60g dietary protein/ kg body weight/day is recommended. FLAVIS® is a product line of hypoprotein foods specially developed for the treatment of CKD.The use of low-protein foods may facilitate the achievement of nutritional goals in terms of protein intake and help patients to follow a low-protein diet.

Gender: All

Ages: 18 Years - Any

Updated: 2025-01-29

Chronic Kidney Disease Stage 3B
Chronic Kidney Disease stage4
Chronic Kidney Disease Stage 5
+1
NOT YET RECRUITING

NCT06760650

Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease

Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.

Gender: All

Ages: 18 Years - Any

Updated: 2025-01-07

Chronic Kidney Disease Stage 4
Chronic Kidney Disease Stage 3B
Chronic Kidney Disease Stage 5
+3
NOT YET RECRUITING

NCT04827290

Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease

Normal-protein and low-AGE through raw or rare proteins diet versus normal-protein and high-AGE diet in stage IIIa-b renal failure patients

Gender: All

Ages: 18 Years - 89 Years

Updated: 2024-04-04

Kidney Failure, Chronic
Chronic Kidney Disease stage3
Chronic Kidney Disease Stage 3B
+3